Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number		000-00935

 

MEDITE Cancer Diagnostics, Inc.

(Exact name of registrant as specified in its charter)

 

10524 Moss Park Rd. Ste-204-357

Orlando, FL 32832

Telephone: [phone]

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.001 per share

(Title of each class of securities covered by this Form)

 

No ne

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)		☐
Rule 12g-4(a)(2)		☐
Rule 12h-3(b)(1)(i)		☐
Rule 12h-3(b)(1)(ii)		☒
Rule 15d-6		☐
Rule 15d-22(b)		☐

 

  Approximate number of holders of record as of the certification or notice date: 372

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this notice to be signed on its behalf by the undersigned hereunto duly authorized person.

 

						MEDITE Cancer Diagnostics, Inc.
Date:		March 22, 2019				By:		/s/ Elmar A. Dave
								Name:		Elmar A. Dave
								Title:		Chief Executive Officer and President